A Single 60 mg Dose of Denosumab Might Improve Hepatic Insulin Sensitivity in Postmenopausal Nondiabetic Severe Osteoporotic Women
Background. The RANKL/RANK/OPG signaling pathway is crucial for the regulation of osteoclast activity and bone resorption being activated in osteoporosis. The pathway has been also suggested to influence glucose metabolism as observed in chronic low inflammation. Aim. To test whether systemic blocka...
Saved in:
Main Authors: | Elena Passeri, Stefano Benedini, Elena Costa, Sabrina Corbetta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2015/352858 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autoimmune Polyendocrine Syndrome 3 Onset with Severe Ketoacidosis in a 74-Year-Old Woman
by: Stefano Benedini, et al.
Published: (2015-01-01) -
Prevention and treatment of recurrent fractures after percutaneous vertebroplasty with denosumab in patients with osteoporotic vertebral compression fractures
by: Shouyu Xiang, et al.
Published: (2025-01-01) -
Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects
by: Flávia De C. Cartolano, et al.
Published: (2017-01-01) -
Effects of Renal Denervation on Insulin Sensitivity and Inflammatory Markers in Nondiabetic Patients with Treatment-Resistant Hypertension
by: Ulla Kampmann, et al.
Published: (2017-01-01) -
Association of Bone Loss with the Upregulation of Survival-Related Genes and Concomitant Downregulation of Mammalian Target of Rapamycin and Osteoblast Differentiation-Related Genes in the Peripheral Blood of Late Postmenopausal Osteoporotic Women
by: Elena V. Tchetina, et al.
Published: (2015-01-01)